|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Saturday"What is COPAXONE?"
CLICK HERE: COPAXONE® (glatiramer acetate injection) is a unique, effective, and well-tolerated therapy that effectively reduces new brain lesions and the frequency of relapses in people with relapsing-remitting multiple sclerosis.
COPAXONE® can help limit the impact of multiple sclerosis on your daily life by reducing relapses. Two clinical trials showed that COPAXONE® reduced relapse rates by 29% (1.19 vs. 1.68 for placebo, p=0.055) and 75% (0.6 vs. 2.4 for placebo, p=0.005) in a two-year period. In addition to reducing relapses, COPAXONE® has also been proven to reduce new, gadolinium-enhancing brain lesions |